ADMA Market Cap History
Below is a table of the ADMA market cap history going back to 11/12/2013:

Date ADMA Market Cap
11/12/201373.33M
3/28/201477.59M
5/9/201468.29M
8/11/201491.06M
11/7/2014113.82M
11/10/2014111.50M
3/6/201585.58M
5/12/201583.08M
8/10/201596.89M
11/10/201597.17M
3/23/201666.53M
5/13/201676.42M
8/12/201683.63M
11/10/201672.55M
2/24/201761.21M
5/12/201755.93M
8/11/201775.83M
11/1/201762.94M
3/9/2018196.22M
5/14/2018193.18M
8/8/2018283.20M
11/5/2018259.57M
3/11/2019180.31M
5/7/2019222.63M
8/6/2019189.22M
11/1/2019294.81M
3/10/2020223.63M

Also see: ADMA Shares Outstanding History
and ADMA YTD Return
ADMA Historical Market Cap:
+19.28% CAGR
ADMA Historical Market Cap: +19.28% CAGR

Mouse over chart for data details
11/12/2013 ...3/10/2020
ADMA Biologics is a biopharmaceutical and immunoglobulin company that manufactures, markets and develops plasma-derived biologics for the treatment of immune deficiencies and the prevention and treatment of certain infectious diseases. Co.'s marketed products consist of: Nabi-HB, which is indicated for the treatment of acute exposure to blood containing Hepatitis B surface antigen; and Bivigam, which is indicated for the treatment of primary humoral immunodeficiency. Co. is also developing a pipeline of plasma-derived therapeutics, including its key pipeline product candidate, RI-002, for the treatment of Primary Immune Deficiency Disease. We show 27 historical shares outstanding datapoints in our ADMA shares outstanding history coverage, used to compute ADMA market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ADMA market cap history over the course of time is important for investors interested in comparing ADMA's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ADMA versus a peer is one thing; comparing ADMA market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ADMA can fluctuate over the course of history. With this page we aim to empower investors researching ADMA by allowing them to research the ADMA market cap history.
Quotes delayed 20 minutes
Get Free SEC filing alerts for ADMA:
ADMA SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
ADMA Biologics (ADMA) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

ADMP Market Cap History
ADMS Market Cap History
ADPT Market Cap History
ADRO Market Cap History
ADUS Market Cap History
ADVM Market Cap History
ADXS Market Cap History
AEMD Market Cap History
AERI Market Cap History
AEZS Market Cap History
More Healthcare companies »

 

ADMA Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2020, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.